Mesa Laboratories, Inc. Share Price
Stocks
MLAB
US59064R1095
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 105.54 USD | +1.10% |
|
+11.74% | +34.45% |
| Market Cap | 577M 504M 463M 432M 818M 54.91B 832M 5.57B 2.16B 26.93B 2.17B 2.12B 92.8B | P/E 2027 * |
77.4x | P/E 2028 * | 49.1x |
|---|---|---|---|---|---|
| Enterprise Value | 577M 504M 463M 432M 818M 54.91B 832M 5.57B 2.16B 26.93B 2.17B 2.12B 92.8B | EV / Sales 2027 * |
2.23x | EV / Sales 2028 * | 2.12x |
| Free-Float |
94.29% | Yield 2027 * |
0.61% | Yield 2028 * | 0.61% |
Last Transcript: Mesa Laboratories, Inc.
| 1 day | +1.10% | ||
| 1 week | +11.74% | ||
| Current month | +6.02% | ||
| 1 month | +0.27% | ||
| 3 months | +19.31% | ||
| 6 months | +34.45% | ||
| Current year | +34.45% |
| 1 week | 96.28 |  | 107.68 |
| 1 month | 87.22 | | 113.99 |
| Current year | 71.06 | | 113.99 |
| 1 year | 55.45 | | 113.99 |
| 3 years | 55.45 | | 155.12 |
| 5 years | 55.45 | | 333.42 |
| 10 years | 55.45 | | 333.42 |
| Manager | Title | Age | Since |
|---|---|---|---|
Siddhartha Kadia
CEO | Chief Executive Officer | 56 | 11/04/2026 |
John Sakys
DFI | Director of Finance/CFO | 57 | 28/10/2012 |
Lyndsey Crennen
AUD | Comptroller/Controller/Auditor | 41 | 31/12/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
John Sullivan
CHM | Chairman | 73 | 31/08/2017 |
Jennifer Alltoft
BRD | Director/Board Member | 57 | 03/03/2019 |
Shannon Hall
BRD | Director/Board Member | 57 | 10/05/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-21 | Sell | Executive/Senior Manager | -2,516 | 0.0455% | ||
| 06-21 | Sell | Chief Financial Officer | -2,827 | 0.0512% | ||
| 06-21 | Sell | Controller/Auditor | -442 | 0.0080% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.10% | +11.74% | +8.01% | -17.87% | 577M | |
| +3.49% | +5.43% | -29.99% | -12.49% | 161B | |
| +5.04% | +3.82% | -6.26% | -5.57% | 101B | |
| +2.80% | +4.23% | +0.40% | +54.09% | 56.12B | |
| -1.22% | -2.88% | +53.69% | +49.87% | 53.35B | |
| +3.39% | +6.98% | -11.03% | -40.12% | 42.13B | |
| +3.50% | +19.81% | - | - | 35.29B | |
| +3.47% | +2.15% | -14.75% | -44.56% | 26.57B | |
| +0.20% | +7.44% | +64.44% | -4.37% | 25.79B | |
| +2.78% | +5.32% | -10.08% | -3.01% | 20.69B | |
| Average | +2.24% | +3.85% | +6.05% | -2.67% | 52.25B | |
| Weighted average by Cap. | +2.73% | +2.01% | -4.03% | +0.13% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 259M 226M 208M 194M 368M 24.67B 374M 2.5B 970M 12.1B 973M 952M 41.7B | 272M 238M 218M 204M 386M 25.91B 393M 2.63B 1.02B 12.71B 1.02B 1B 43.79B |
| Net income | 7.57M 6.61M 6.07M 5.66M 10.73M 720M 10.91M 73.1M 28.33M 353M 28.41M 27.79M 1.22B | 12.13M 10.6M 9.74M 9.08M 17.21M 1.16B 17.5M 117M 45.43M 567M 45.56M 44.57M 1.95B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/07/26 | US$105.54 | +1.10% | 117,340 |
| 01/07/26 | US$104.39 | +4.86% | 143,944 |
| 30/06/26 | US$99.55 | +0.02% | 208,646 |
| 29/06/26 | US$99.53 | -2.82% | 145,403 |
| 26/06/26 | US$102.42 | +4.35% | 257,312 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MLAB Stock
Select your edition
All financial news and data tailored to specific country editions
